IV Equipment Market

Executive Summary

IV Equipment Market was valued at US $13.96 billion in 2021 and is projected to grow at 6.97% CAGR over the forecast period to reach US $20.91 billion by 2027. IV Equipment Market represented US $1.76 billion opportunity over 2019-2021 and estimated to create US $6.95 billion opportunity in 2027 over 2021.

IV Equipment from Consainsights analyses the IV Equipment Market in the Life Sciences industry over the forecast period to 2027.

IV Equipment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

IV Equipment segmentation includes Product, End User, Region and Geography.

Based on the Product, the IV Equipment analysis covers IV Catheters, Administration Sets, Infusion Pumps, Securement Devices, Stopcocks & Check Valves, Drip Chambers, Needleless Connectors, Other IV Equipment.

In Product segment, IV Catheters segment has highest cagr growth of 6.17%.

Based on the End User, the IV Equipment analysis covers Hospitals & Clinics, Home Care, Ambulatory Care Centers.

In End User segment, Hospitals & Clinics segment has highest cagr growth of 6.17%.

Based on the Region, the IV Equipment analysis covers North America, Europe, Asia-Pacific, Latin America, Middle East And Africa.

In Region segment, North America segment has highest cagr growth of 6.17%.

Based on the region, the IV Equipment analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Becton, Dickinson And Company (Bd), B. Braun Melsungen Ag, Baxter International Inc., Fresenius Se & Co. Kgaa, Icu Medical, Inc., Smiths Medical (A Division of Smiths Group Plc), C.R. Bard, Inc., Terumo Corporation, Moog Inc., Angiodynamics, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, IV Catheters segment has the highest revenue of US $5.22 billion and is expected to grow at CAGR of 6.17% by 2027 IV Catheters segment has highest cagr growth of 6.17%.

IV Catheters

IV Catheters segment was valued at US $4.56 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $7.82 billion by 2027. IV Catheters segment represented US $0.66 billion opportunity over 2019-2021 and estimated to create US $2.60 billion opportunity in 2027 over 2021.

Administration Sets

Administration Sets segment was valued at US $2.99 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $5.13 billion by 2027. Administration Sets segment represented US $0.43 billion opportunity over 2019-2021 and estimated to create US $1.71 billion opportunity in 2027 over 2021.

Infusion Pumps

Infusion Pumps segment was valued at US $1.85 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $3.18 billion by 2027. Infusion Pumps segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.06 billion opportunity in 2027 over 2021.

Securement Devices

Securement Devices segment was valued at US $1.10 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $1.89 billion by 2027. Securement Devices segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.63 billion opportunity in 2027 over 2021.

Stopcocks & Check Valves

Stopcocks & Check Valves segment was valued at US $0.71 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $1.21 billion by 2027. Stopcocks & Check Valves segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.40 billion opportunity in 2027 over 2021.

Drip Chambers

Drip Chambers segment was valued at US $0.54 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $0.92 billion by 2027. Drip Chambers segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.31 billion opportunity in 2027 over 2021.

Needleless Connectors

Needleless Connectors segment was valued at US $0.29 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $0.49 billion by 2027. Needleless Connectors segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.16 billion opportunity in 2027 over 2021.

Other IV Equipment

Other IV Equipment segment was valued at US $0.16 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $0.27 billion by 2027. Other IV Equipment segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals & Clinics segment has the highest revenue of US $7.49 billion and is expected to grow at CAGR of 6.17% by 2027 Hospitals & Clinics segment has highest cagr growth of 6.17%.

Hospitals & Clinics

Hospitals & Clinics segment was valued at US $6.55 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $11.22 billion by 2027. Hospitals & Clinics segment represented US $0.94 billion opportunity over 2019-2021 and estimated to create US $3.73 billion opportunity in 2027 over 2021.

Home Care

Home Care segment was valued at US $4.52 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $7.75 billion by 2027. Home Care segment represented US $0.65 billion opportunity over 2019-2021 and estimated to create US $2.58 billion opportunity in 2027 over 2021.

Ambulatory Care Centers

Ambulatory Care Centers segment was valued at US $1.13 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $1.94 billion by 2027. Ambulatory Care Centers segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.65 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $5.83 billion and is expected to grow at CAGR of 6.17% by 2027 North America segment has highest cagr growth of 6.17%.

North America

North America segment was valued at US $5.09 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $8.73 billion by 2027. North America segment represented US $0.73 billion opportunity over 2019-2021 and estimated to create US $2.90 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $2.87 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $4.93 billion by 2027. Europe segment represented US $0.41 billion opportunity over 2019-2021 and estimated to create US $1.64 billion opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $2.38 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $4.08 billion by 2027. Asia-Pacific segment represented US $0.34 billion opportunity over 2019-2021 and estimated to create US $1.36 billion opportunity in 2027 over 2021.

Latin America

Latin America segment was valued at US $1.39 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $2.38 billion by 2027. Latin America segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.79 billion opportunity in 2027 over 2021.

Middle East And Africa

Middle East And Africa segment was valued at US $0.46 billion in 2019 and is projected to grow at 6.17% CAGR over the forecast period to reach US $0.80 billion by 2027. Middle East And Africa segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.26 billion opportunity in 2027 over 2021.